Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

NCT05122559 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis, Secondary Progressive

Interventions

DRUG: N-acetyl cysteine
DRUG: Placebo

Sponsor

Emmanuelle Waubant, MD PhD

Collaborators

[object Object]